|
|
LDL Cholesterol Level Predicts HCV Therapy Response in Patients With HIV Coinfection
|
| Link ID |
6958 |
| Title |
LDL Cholesterol Level Predicts HCV Therapy Response in Patients With HIV Coinfection |
| Url |
http://www.medscape.com/viewarticle/576510?src=rss |
| Description |
Patients coinfected with hepatitis C virus (HCV) and HIV who have high pretreatment LDL cholesterol levels are more likely to respond to HCV therapy than are similar patients with low LDL cholesterol levels, according to a report in the May 11th issue of AIDS. Reuters Health Information |
| Category |
Articles > HIV/AIDS |
| Keywords |
|
| Date |
Jun 25, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > HIV/AIDS |
| 1. |
Youth With HIV Who Interrupt Treatment Risk Rapid Deterioration
|
|
|
Unstructured treatment interruptions in children and adolescents with HIV infection are associated with rapid increases in HIV RNA and precipitous declines in CD4+ cell counts, often resulting in infectious complications requiring hospitalization. Reuters Health Information
|
| 2. |
Earlier Initiation of Antiretroviral Therapy May Reduce Toxicities
|
|
|
Initiation of antiretroviral therapy at CD4+ counts greater than 200 cells/microliter may reduce the incidence of peripheral neuropathy, anemia, and renal insufficiency, according to a report in the January 1st Journal of Acquired Immune Deficiency Syndromes. Reuters Health Information
|
|
|
